The value of periodic spirometry for early recognition of long-term excessive lung function decline in individuals

Journal of Occupational and Environmental Medicine

Volumn 54, Issue 12, 2012, Pages 1506-1512

  Hnizdo, Eva ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONSTRUCTION WORK; EARLY DIAGNOSIS; FEMALE; FIRE FIGHTER; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PAPER INDUSTRY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SPIROMETRY; WORKPLACE;

ADULT; CONSTRUCTION INDUSTRY; DISEASE PROGRESSION; FIREFIGHTERS; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL HEALTH SERVICES; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 84871796203     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3182664811     Document Type: Article

References (28)

1. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow-up study. Thorax. 2003;58:388- 393.
2. Tockman MS, Pearson JD, Fleg JL, et al. Rapid decline in FEV1. A new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med. 1995;151:390-398.
3. Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax. 2006;61:472-477.
4. Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med. 2006;173:985-990.
5. Baughman P, Marott JL, Lange P, Andrew M, Hnizdo E. Health outcomes associated with lung function decline and respiratory symptoms and disease in a community cohort. COPD: J Chronic Obstructive Pulmonary Dis. 2011;48:103-113.
6. Baughman P. An Epidemiological Assessment of Lung Function Decline as a Predictor of Morbidity and Mortality, Doctoral Dissertation. Morgantown, WV: West Virginia University; 2011.
7. Lange P. Spirometric findings as predictors of survival. Thorax. 2011;66:1-2.
8. Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J. 1991;4:1080- 1087.
9. Hogg JC, Pierce RA. Remodeling of peripheral lung tissue in COPD. Eur Respir J. 2008;31:913-914.
10. Vestbo J, Rennard S. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed - urgently. Am J Respir Crit Care Med. 2010;82:863- 869.
11. Hankinson JL, Wagner GR. Medical screening using periodic spirometry for detection of chronic lung disease. Occup Med. 1993;8:353-361.
12. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002;166:675-679.
13. Musk AW, Peters JM, Bernstain L, Rubin C,Monroe CB. Pulmonary function in firefighters: a six-year follow-up in the Boston fire department. Am J Indust Med. 1982;3:3-9.
14. Pahwa P, Senthilselvan A,McDuffie HH, Dosman JA. Longitudinal decline in lung function measurements among Saskatchewan grain workers. Can Respir J. 2003;10:135-141.
15. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;458-463.
16. Townsend MC. Evaluating pulmonary function change over time in the occupational setting. ACOEM evidence-based statement. J Occup Environ Med. 2005;47:1307-1316.
17. Hnizdo E, Berry A, Hakobyan A, Beeckman-Wagner L-A, Catlett L.Worksite wellness program for respiratory disease prevention in heavy construction workers. J Occup Environ Med. 2011;53:274-281.
18. Hnizdo E, Glindmeyer HW, Petsonk EL. Workplace spirometry monitoring for respiratory disease prevention: a method review. Int J Tuberc Lung Dis. 2010;14:1-10.
19. Wang M, Petsonk EL. Repeated measures of FEV1 over six to twelve months: what change is abnormal? J Occup Environ Med. 2004;46:591-595.
20. Wang ML, Vashia BH, Petsonk LE. Interpreting periodic lung function tests in individuals. The relationship between 1- to 5-year and long-term FEV1 changes. Chest. 2006;130:493-499.
21. Hnizdo E, Hakobyan A, Fleming J, Beeckman-Wagner L. Spirometry-based medical monitoring: spirometry quality vs. data precision. J Occup Environ Med. 2011;53:1205-1209.
22. Glindmeyer H, Lissack T. A network approach to national respiratory health care. In: RubinM, eds. Computerization and Automation in Health Facilities. Boca Raton, FL: CRC Press, Inc; 1984:1-16.
23. Hnizdo E, Yu L, Freyder L, Lefante J, Glindmeyer HW. Precision of longitudinal lung function measurements - monitoring and interpretation. Occup Environ Med. 2005;62:695-701.
24. Hankinson JL, Odenkrantz JR, Fedan KB. Spirometric reference values from a smaple of the general US population. Am J Respir Crit Care Med. 1999;159:179-187.
25. Buist AS, Vollmer WM. The use of lung function tests in identifying factors that affect lung growth and aging. Stat Med. 1988;7:11-18.
26. Schlesselman JJ. Planning a longitudinal study: II. Frequency ofmeasurement and study duration. J Chron Dis. 1973;26:553-558.
27. Spirometry Longitudinal Data Analysis (SPIROLA) software. Available at: http://www.cdc.gov/niosh/topics/spirometry/spirola.html. Accessed August 13, 2012.
28. Gallagher EJ. Clinical Utility of likelihood ratios. Ann Emerg Med. 1998;31:391-397.